Stem-Loop Recognition by DDX17 Facilitates miRNA Processing and Antiviral Defense  by Moy, Ryan H. et al.
Stem-Loop Recognition
by DDX17 Facilitates miRNA
Processing and Antiviral Defense
Ryan H. Moy,1 Brian S. Cole,2 Ari Yasunaga,1 Beth Gold,1 Ganesh Shankarling,2 Andrew Varble,3 Jerome M. Molleston,1
Benjamin R. tenOever,3 Kristen W. Lynch,2 and Sara Cherry1,*
1Department of Microbiology, Penn Genome Frontiers Institute
2Department of Biochemistry and Biophysics
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA
3Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
*Correspondence: cherrys@mail.med.upenn.edu
http://dx.doi.org/10.1016/j.cell.2014.06.023SUMMARY
DEAD-box helicases play essential roles in RNA
metabolism across species, but emerging data sug-
gest that they have additional functions in immunity.
Through RNAi screening, we identify an evolution-
arily conserved and interferon-independent role for
the DEAD-box helicase DDX17 in restricting Rift Val-
ley fever virus (RVFV), a mosquito-transmitted virus
in the bunyavirus family that causes severe morbidity
and mortality in humans and livestock. Loss of
DrosophilaDDX17 (Rm62) in cells and flies enhanced
RVFV infection. Similarly, depletion of DDX17 but not
the related helicase DDX5 increased RVFV replica-
tion in human cells. Using crosslinking immunopre-
cipitation high-throughput sequencing (CLIP-seq),
we show that DDX17 binds the stem loops of host
pri-miRNA to facilitate their processing and also an
essential stem loop in bunyaviral RNA to restrict
infection. Thus, DDX17 has dual roles in the recogni-
tion of stem loops: in the nucleus for endogenous mi-
croRNA (miRNA) biogenesis and in the cytoplasm for
surveillance against structured non-self-elements.
INTRODUCTION
RNA helicases control nearly every facet of RNA metabolism,
including transcription, splicing, miRNA biogenesis, translation,
and decay (Linder and Jankowsky, 2011). Comprising the largest
family of helicases, the DEAD-box proteins are found in all three
kingdoms of life and share 12 conserved motifs, including the
DEAD motif characterized by the amino acids Asp-Glu-Ala-
Asp. Although DEAD-box proteins are most appreciated for their
roles in RNAmetabolism, some have important functions in anti-
viral defense. For example, mammalian retinoic acid-inducible
gene 1 (RIG-I/DDX58) and myeloma differentiation-associated
factor 5 (MDA-5), collectively termed RIG-I-like receptors
(RLRs), recognize non-self-elements in viral RNAs such as764 Cell 158, 764–777, August 14, 2014 ª2014 Elsevier Inc.double-stranded RNA (dsRNA) and 50-triphosphorylated RNA,
leading to the transcriptional induction of Type I interferon
(IFN-I) and proinflammatory cytokines (Loo and Gale, 2011).
However, some viruses are not restricted by RLRs in some con-
texts or encode potent RLR antagonists, and thus additional
sensors may have evolved (Bowie and Unterholzner, 2008).
Although RLRs are not strictly conserved in invertebrates such
as mosquitoes and Drosophila, insects use a related helicase to
combat viral infection. The DEAD-box helicase Dicer-2 (Dcr-2) is
a core component of the RNAi pathway that recognizes double-
stranded or structured viral RNAs and cleaves them into 21 nt
small-interfering RNAs (siRNAs) (Ding and Voinnet, 2007; Sabin
et al., 2013). Virus-derived siRNAs are loaded into an Argo-
naute-2 (Ago2)-containing RNA-induced silencing complex
that cleaves viral RNA. Additionally, during Drosophila C virus
(DCV) infection, Dcr-2 controls induction of the antiviral gene
Vago (Deddouche et al., 2008).
More recently, several other DEAD-box proteins have been
implicated in sensing viral nucleic acids or regulating down-
stream signaling. For example, DDX41 recognizes intracellular
DNA and bacterial cyclic dinucleotides (Parvatiyar et al., 2012;
Zhang et al., 2011b), whereas a complex of DDX1, DDX21, and
DHX36 senses viral dsRNA specifically in dendritic cells (Zhang
et al., 2011a). Other recently identified helicase sensors or com-
ponents of antiviral signaling pathways include DDX3, DHX9,
and DDX60 (Kim et al., 2010; Miyashita et al., 2011). Thus, the
landscape of DEAD-box helicases in innate immunity is more
diverse than previously appreciated, and many antiviral heli-
cases likely remain obscure.
As many aspects of innate immunity are conserved in flies as
well as many DEAD-box helicases, we performed an RNAi
screen to identify novel antiviral helicases. We focused on the
arthropod-borne virus (arbovirus) Rift Valley fever virus (RVFV),
a tri-segmented negative-sense RNA virus in the bunyavirus
family (Ikegami and Makino, 2011). In humans, RVFV infection
typically causes an acute febrile illness but can progress to
more severe manifestations such as encephalitis and hemor-
rhagic fever with 1%–3% mortality. In livestock, infection is
particularly lethal with 100% abortion rates and near 100%
fatality in neonates (Ikegami and Makino, 2011). No effective
vaccines or therapeutics exist for RVFV infection, and therefore
additional targets for pharmacologic intervention are needed.
Furthermore, we have shown that RVFV is not restricted by
RLRs in some contexts including fibroblasts, suggesting that
other sensors may restrict this pathogen (Moy et al., 2014).
We identified Drosophila Rm62 as a novel host factor that re-
stricts RVFV infection in vitro and in vivo. This restriction was
specific for bunyaviruses, as Rm62 also controlled the replica-
tion of the distantly related bunyavirus La Crosse virus (LACV),
but not viruses from the three other families tested. Remarkably,
the antiviral role of Rm62 was conserved in human cells, as the
human homolog DDX17 restricted RVFV infection. DDX17 was
identified in a high-molecular-weight complex with Drosha and
later shown to regulate the Microprocessor complex that medi-
ates pri-miRNA processing and miRNA biogenesis, but its direct
RNA targets are not fully known (Fukuda et al., 2007; Gregory
et al., 2004; Mori et al., 2014; Suzuki et al., 2009). Using CLIP-
seq, we found that in addition to binding cellular RNAs, DDX17
also interacts with RVFV RNA, likely via structured viral RNA el-
ements. We found striking similarities in the mode of recognition
for host and viral RNA: DDX17 binds a subset of pri-miRNA hair-
pins along with a well-characterized hairpin on the RVFV
genome. Cloning this hairpin into Sindbis virus (SINV) decreased
its replication in a DDX17-dependent manner in human and in-
sect cells, indicating a direct antiviral function for DDX17 binding
to viral RNA. Taken together, these data expand our understand-
ing of DDX17 recognition of cellular and viral RNAs as well as the
scope of DEAD-box helicases in antiviral immunity, demon-
strating that the immune functions of DEAD-box genes can be
evolutionarily conserved from insects to humans.
RESULTS
DEAD-BoxHelicase ScreenReveals that Rm62Restricts
RVFV in Drosophila Cells
Because DEAD-box helicases are widely conserved across spe-
cies (Linder and Jankowsky, 2011), we performed a targeted
RNAi screen in Drosophila cells to identify novel factors that
control RVFV infection. Drosophila DL1 cells were treated with
a panel of dsRNAs targeting 23 DEAD-box helicases that are
conserved in humans (Table S1 available online). The cells
were then infected with the MP12 strain of RVFV, stained for
RVFV nucleoprotein (N) to monitor infection and analyzed using
automated microscopy (Hopkins et al., 2013).
Implementing a cut-off of a 2-fold increase in percent infection
and a p < 0.05 across three independent experiments, we iden-
tified three DEAD-box helicase genes that restrict RVFV infection
without impacting cell viability: me31B, CG10333, and Rm62
(Figures 1A and 1B). These results were independently corrobo-
rated by microscopy with depletion of Rm62, CG10333, or
me31B resulting in increased infection (Figure 1C). The helicase
me31B (DDX6) is a component of cytoplasmic granules known
as processing bodies and activates mRNA decapping (Coller
et al., 2001). Importantly, a recent genome-wide RNAi screen
in Drosophila cells identified me31B as a RVFV restriction factor,
validating our helicase screen (Hopkins et al., 2013). CG10333 is
the homolog of human DDX23/PRP28, a component of the U5
small ribonucleoprotein that promotes spliceosome assemblyduring pre-mRNA splicing (Staley and Guthrie, 1999). Rm62,
which has two human homologs (DDX5/p68 and DDX17/p72)
(Figure S1A), has been studied in several contexts in flies and
humans (Fuller-Pace, 2013). In Drosophila, Rm62 has been
shown to promote dsRNA-mediated RNAi (Ishizuka et al.,
2002), modulate chromatin insulation (Lei and Corces, 2006),
and facilitate resilencing of transcription loci after stimulation
(Boeke et al., 2011; Buszczak and Spradling, 2006). In mammals,
DDX5 and DDX17 have been associated with transcriptional
coactivation and miRNA processing, among other functions
(Fukuda et al., 2007; Fuller-Pace, 2013; Mori et al., 2014).
To further validate the antiviral activity of Rm62 and CG10333,
we targeted these genes using independent dsRNAs, observ-
ing increased infection by immunofluorescence (Figure S1B),
and verified efficient Rm62 silencing (Figure S1C). Rm62,
CG10333, and me31B knockdown also increased RVFV glyco-
protein Gn (Figure 1D) and RVFV RNA (Figure 1E), additional
readouts of viral replication. Thus, these data identify Rm62
and CG10333 as new RVFV restriction factors.
Rm62 Is Antiviral against RVFV in Adult Flies
As Rm62 displayed the most potent antiviral effect against RVFV
infection in Drosophila cells (Figures 1D and 1E), we next deter-
mined whether Rm62 also controls viral replication at the organ-
ismal level. To silence Rm62 in adult flies, we performed in vivo
RNAi by crossing transgenic flies expressing a UAS-controlled
inverted repeat transgene directed against Rm62 (UAS-Rm62
IR) to heat shock-driven Gal4 (hs-Gal4). We validated Rm62
depletion by northern blot (Figure S2A). Rm62-silenced flies
(hs-Gal4 > UAS-Rm62 IR) and their sibling controls (+ > UAS-
Rm62 IR) were challenged with RVFV and monitored for survival.
Compared to control flies, Rm62-silenced flies exhibited
increased mortality after infection (Figure 2A). This survival
defect was associated with significantly elevated viral RNA repli-
cation, suggesting that Rm62 restricts RVFV infection in vivo
(Figures 2B and 2C). Because the transgene is only expressed
in adults, the increased susceptibility is not due to a develop-
mental requirement for Rm62. Moreover, Rm62 depletion did
not impact survival of uninfected flies (Figure S2B).
To validate our in vivo RNAi results and control for potential off-
target effects, we tested previously characterized transheterozy-
gous Rm62 mutant flies that had substantially reduced Rm62
protein expression (Buszczak and Spradling, 2006). RVFV-in-
fected Rm62mutant flies (Rm62CB02119/Rm6201086), but not unin-
fected flies, showed a dramatic increase in mortality compared to
sibling controls (Rm62CB02119/+) (Figures 2D and S2C). Rm62mu-
tants also demonstrated significantly elevated RVFVRNA replica-
tion, similar to Rm62-silenced flies (Figures 2E and 2F). Taken
together, these data reveal an in vivo requirement for Rm62 in
controlling RVFV infection and protecting against lethality.
Rm62 Specifically Restricts Bunyaviral Infection in
Drosophila
We next evaluated the specificity of Rm62 by testing its role
during infection with additional viruses. To test whether Rm62
restricts other bunyaviruses, we challenged Rm62-silenced
Drosophila cells with LACV, a mosquito-transmitted bunyavirus
that causes encephalitis in humans. Rm62 depletion dramaticallyCell 158, 764–777, August 14, 2014 ª2014 Elsevier Inc. 765
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Figure 1. DEAD-Box Helicase Screen Identifies RVFV Restriction Factors
(A) Drosophila cells were treated with the indicated dsRNA, infected with RVFV (moi = 0.04), and processed for immunofluorescence (IF) and automated
microscopy 30 hpi. Average fold increase in percent infection compared to control dsRNA-treated cells is shown. Mean ± SEM.
(B) Average fold change in total nuclei from (A). Mean ± SEM.
(C) Representative IF image of RVFV-infected Drosophila cells treated with the indicated dsRNA.
(D) Immunoblot for RVFV protein (Gn) from infected cells treated with the indicated dsRNA 30 hpi.
(E) Average fold increase in RVFV RNA in cells treated with the indicated dsRNA as quantified by northern. Mean ± SEM; *p < 0.05, Student’s t test.
All data represent three independent experiments. See also Figure S1 and Table S1.increased the amount of recovered LACV RNA, indicating that
Rm62 also controls LACV replication in vitro (Figures 3A and
3B). Furthermore, LACV-infected Rm62 mutant flies exhibited
increased mortality and LACV RNA replication, with an approxi-
mately 35-fold elevation in LACV N expression (Figures 3C–3E).766 Cell 158, 764–777, August 14, 2014 ª2014 Elsevier Inc.These data indicate that Rm62 restricts both LACV and RVFV in
cells and flies.
To examine whether Rm62’s antiviral activity is limited to
bunyaviruses or functionsmore broadly, we tested additional hu-
man arboviruses from distinct classes. Vesicular stomatitis virus
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Figure 2. Rm62 Restricts RVFV Infection in Adult Flies
(A) Rm62-silenced flies (Hs-Gal4 > UAS-Rm62 IR) or sibling controls were infected with RVFV and monitored for survival. Mean ± SEM; p < 0.05, log-rank test.
(B) Northern for RVFV RNA from infected flies at 6 and 9 days post-infection (dpi).
(C) Representative RNA blot increase in RVFV S segment RNA from Rm62-silenced flies 6 dpi. Mean ± SEM; *p < 0.05, Student’s t test.
(D) Survival of Rm62 mutant flies (Rm62CB02119/Rm6201086; MUT) or sibling control flies (Rm62CB02119/+; HET) infected with RVFV. Mean ± SEM; p < 0.001, log-
rank test.
(E) Representative RNA blot for RVFV RNA from RVFV-infected flies 6 dpi.
(F) Fold increase in RVFV S segment RNA in Rm62 mutant flies quantified by RNA blot. Mean ± SEM; *p < 0.05, Student’s t test.
All data represent at least three independent experiments. See also Figure S2.(VSV) is a nonsegmented negative-sense RNA virus in the Rhab-
dovirus family, whereas SINV is a positive-sense RNA alphavi-
rus. Notably, we observed no increase in VSV or SINV protein
expression in virus-challenged Drosophila cells treated with
Rm62 dsRNA (Figures S3A and S3B). In addition, we infected
Rm62 mutant flies with VSV, SINV, and DCV, a picorna-like pos-
itive-sense RNA virus that is a natural Drosophila pathogen.
Rm62 mutant flies showed no increase in mortality with DCV,
VSV, or SINV infection (Figures 3F–3H). Furthermore, we
observed no increase in DCV protein, VSV RNA, or SINV RNA
in Rm62 mutant flies (Figures 3I–3K), demonstrating that Rm62
does not restrict these viruses in vivo. Therefore, Rm62 is a se-
lective restriction factor for bunyaviruses in flies.
Human DDX17 Controls RVFV and LACV Infection
DEAD-box helicases are broadly conserved across species, with
humans and mammals encoding two homologs of Rm62: DDX5
and DDX17 (Figure S1A). These proteins have both overlappingand unique functions, but their role in immunity is not defined.
Thus, we evaluated whether DDX5 or DDX17 restrict bunyavirus
infection in human cells.
To silence DDX5 and DDX17 expression, we transfected a
human osteosarcoma cell line (U2OS cells) with gene-specific
siRNAs or a nontargeting control siRNA (Figure S4A). Inter-
estingly, whereas DDX17 silencing had no effect on DDX5
expression, DDX5 knockdown increased DDX17 protein levels,
suggesting that DDX5 negatively regulates DDX17 expression,
which has been observed in HeLa cells (Jalal et al., 2007).
Compared to control cells, DDX17-depleted cells showed a sig-
nificant increase in percent infection and viral RNA (Figures 4A–
4D). In contrast, we observed no difference in RVFV infection
with DDX5 depletion, suggesting that DDX17 specifically limits
RVFV replication in human cells. Independent siRNAs against
DDX17 also augmented RVFV infection (Figures S4B and S4C).
Furthermore, DDX17 but not DDX5 silencing increased LACV
infection in U2OS cells (Figures 4E–4G). Taken together, theseCell 158, 764–777, August 14, 2014 ª2014 Elsevier Inc. 767
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Figure 3. Rm62 Specifically Restricts Bunyavirus Infection in Flies
(A) Drosophila cells were treated with the indicated dsRNA and infected with LACV (moi = 1). Viral RNA (LACV N) was monitored by RNA blot 36 hpi.
(B) Fold increase in LACV N RNA levels. Mean ± SEM; *p < 0.05, Student’s t test.
(C) Survival of LACV- infected Rm62 mutant (Rm62CB02119/Rm6201086; MUT) or control flies (Rm62CB02119/+; HET). Mean ± SEM; p < 0.005, log-rank test.
(D) Northern for LACV N mRNA from LACV-infected flies 6 dpi.
(E) Fold increase in LACV N in Rm62 mutant flies. Mean ± SEM; *p < 0.05, Student’s t test.
(F) Survival of DCV-infected flies. Mean ± SEM.
(G) Survival of VSV-GFP-infected flies. Mean ± SEM.
(legend continued on next page)
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data indicate that DDX17 restriction of bunyavirus infection is
functionally conserved from flies to human cells.
Next we tested whether overexpression of DDX17 limits RVFV
replication. Compared to control GFP overexpression, ectopic
DDX17 expression reduced RVFV protein accumulation (Fig-
ure S4D) and the percentage of infected cells (Figure S4E). These
results demonstrate that DDX17 may be limiting and that
increased expression can modestly attenuate RVFV infection.
Finally, we tested the specificity of human DDX17 by chal-
lenging U2OS cells with VSV. Whereas DDX17-depleted cells
demonstrated increased RVFV Gn protein (Figure 4H), DDX17
silencing had no effect on VSV protein expression (Figure 4I).
Therefore, as in Drosophila, DDX17 restricts the two bunyavi-
ruses RVFV and LACV but not VSV, indicating selectivity for re-
stricting bunyaviruses.
Some DEAD-box helicases such as RIG-I and MDA-5 control
virus-induced IFN-I expression. To determine whether DDX17
similarly regulates IFN-I production, we tested whether DDX17
silencing impacts upregulation of the interferon-stimulated gene
(ISG) Ifit1 (Terenzi et al., 2006). Although VSV and RVFV infection
induced Ifit1 RNA expression at 16 hr post-infection (hpi), DDX17
knockdown did not abrogate this response; in fact, Ifit1 levels
were higher in DDX17-silenced cells with RVFV infection, most
likely due to increased viral replication (Figures 4J and 4K).
RVFV infection also did not induce IFNa or IFNb expression, likely
because the virus encodes a potent interferon antagonist, NSs
(Figures S4F and S4G). Notably, DDX17 depletion did not impact
the expression of these genes, as well as IkBa, IRF7, and DDX58
(Figures S4H–S4J). Thus, our data suggest that DDX17 restricts
RVFV infection in an interferon-independent manner.
Identification of DDX17-Bound RNAs by CLIP-Seq
Because DEAD-box helicases function as RNA-binding proteins,
we hypothesized that DDX17 may directly bind RVFV RNAs to
inhibit viral replication. To determine the specific RNAs bound
to endogenous DDX17, we performed CLIP-seq, a method for
purifying RNA-binding protein targets from cells under stringent
conditions (Darnell, 2010). Briefly, uninfected or RVFV-infected
U2OS cells were UV-irradiated, and endogenous DDX17-bound
RNAs were digested to 100 nt fragments, immunoprecipitated
from cell lysates with anti-DDX17 or anti-FLAG as a control, and
radiolabeled for visualization. We observed efficient depletion of
DDX17 from the lysates with anti-DDX17 but not anti-FLAG (Fig-
ure 5A). Autoradiography of RNA-protein complexes revealed
extensive signal for anti-DDX17 but not anti-FLAG immunopre-
cipitations, suggesting enrichment for DDX17-bound RNAs (Fig-
ure 5B). cDNA libraries were then generated from purified RNAs
and submitted for Illumina deep-sequencing.
From threepooledDDX17-CLIP experiments,weobtained80
million raw reads and 90 million raw reads from uninfected and
infectedcells, respectively (Figure5C).Wegeneratedacomposite
genome index incorporating the hg19 human genome and three(H) Survival of SINV-GFP-infected flies. Mean ± SEM.
(I) Immunoblot for DCV capsid from DCV-infected flies 4 dpi.
(J) Fold increase in viral RNA (GFP) from VSV-GFP-infected flies 6 dpi, quantified
(K) Fold increase in viral RNA (GFP) from SINV-GFP-infected flies 6 dpi, quantifie
All data represent three independent experiments. See also Figure S3.genomic segments of RVFV (L, M, S), with over 55% of reads
aligning unambiguously to the composite genome (unique align-
ments). Collapsed alignments were obtained by removing PCR
duplicates and retaining only one alignment for each 50 coordi-
nate. Genomic intervals with at least two overlapping alignments
were clustered together generating the alignment clusters. This
yielded 733,542 clusters for uninfected cells and 426,135 clusters
from RVFV-infected cells. Alignment clusters within human pre-
mRNA loci were further searched for significant peaks (false
discovery rate [FDR] < 0.001) using an empirical algorithm (Shan-
karlingetal., 2014).DDX17pre-mRNApeaksshowedstrongover-
lap between uninfected and infected cells (Figure 5D), indicating
that the overall profile of DDX17-bound cellular RNAs is similar
during infection. Next, we determined the transcript features of
DDX17 pre-mRNA peaks (Figure 5E). Interestingly, DDX17 peaks
were enriched in coding exons, 50 UTRs, and 30 UTRs, suggesting
that DDX17 preferentially binds mature mRNA. Hexamer enrich-
ment analysis of CLIP-seq peaks within protein-coding genes
showed a bias for CT- and CA-repeat elements (Figure 5F
and Table S2). Together, these data indicate both location and
sequence preference for DDX17 binding to mRNAs.
To understand the functional targets of DDX17, we used
DAVID to identify KEGGGO terms enriched among protein-cod-
ing genes associated with DDX17CLIP-seq peaks.We observed
enrichment for cell adhesion as well as several cellular signaling
pathways (Figure S5A). Intriguingly, one of the most overrepre-
sented KEGG pathways was mitogen-activated protein kinase
(MAPK) signaling (Figure S5B). Previous data suggest that
MAPK-activated protein kinase 2 (MK2) physically interacts
with DDX5 to control its localization, and that DDX5/DDX17 regu-
late splicing of p38 MAPK (Hong et al., 2013; Samaan et al.,
2013). Thus, DDX17-bound RNAs identified in our experiments
overlap with known targets in MAPK signaling, suggesting that
the CLIP-seq peaks reflect the biological activity of DDX17.
DDX17 Directly Binds to pri-miRNA Stem Loops
In addition to roles in transcriptional regulation and alternative
splicing, DDX17 has been linked to miRNA biogenesis. DDX5
and DDX17 are components of the Microprocessor complex,
which processes the pri-miRNA transcript into the 60–70 nt
stem-loop intermediate known as the pre-miRNA (Davis et al.,
2008; Gregory et al., 2004; Mori et al., 2014; Suzuki et al.,
2009). Loss of DDX17 results in decreased expression of a sub-
set but not all miRNAs (Fukuda et al., 2007; Mori et al., 2014).
Therefore, as further validation of our CLIP-seq data, we also
analyzed the intersection of DDX17 CLIP signal with annotated
miRNA stem loops.
We observed 160 pri-miRNA loci that were associated with
DDX17 CLIP clusters (Table S3). There was strong correlation in
normalized CLIP signal within pri-miRNAs from uninfected and
RVFV-infected samples (Figure 6A), suggesting that similar pri-
miRNAs are bound by DDX17 in uninfected and infected cells.by northern. Mean ± SEM.
d by Northern. Mean ± SEM.
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Figure 4. DDX17 Controls RVFV and LACV Replication in Human Cells
(A) Representative IF image of RVFV-infected U2OS cells (moi = 0.3) transfected with the indicated siRNAs 16 hpi.
(B) Relative percent RVFV infection as quantified by automated image analysis. Mean ± SEM; *p < 0.05, Student’s t test.
(C) Representative RNA blot from siRNA-transfected U2OS cells infected with RVFV 16 hpi.
(D) Fold increase in RVFV N mRNA compared to control siRNA-treated U2OS cells as quantified by northern. Mean ± SEM; *p < 0.05, Student’s t test.
(E) Representative IF image of LACV-infected U2OS cells (moi = 0.3) transfected with the indicated siRNAs 16 hpi.
(F) Relative percent LACV infection as quantified by automated image analysis. Mean ± SEM; *p < 0.05, Student’s t test.
(G) Representative northern for LACV N mRNA from siRNA-transfected U2OS cells infected with LACV 16 hpi.
(H) U2OS cells were transfected with the indicated siRNAs and infected with RVFV for 16 hr. Viral protein (Gn) was monitored by immunoblot.
(I) Immunoblot for viral protein (GFP) from U2OS cells treated with the indicated siRNAs and infected with VSV-GFP at 16 hpi (moi = 1).
(J) Ifit1mRNA expression from uninfected or VSV-infected U2OS cells treated with the indicated siRNAs at 16 hpi by qRT-PCR, normalized to uninfected siCON-
treated cells. Mean ± SEM.
(K) Ifit1mRNAexpression from uninfected or RVFV-infectedU2OS cells treatedwith the indicated siRNAs at 16 hpi by qRT-PCR, normalized to uninfected siCON-
treated cells. Mean ± SEM.
All data represent three independent experiments. See also Figure S4.
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Figure 5. CLIP-Seq Analysis of DDX17-
Bound RNAs from Uninfected and RVFV-In-
fected U2OS Cells
(A) Immunoblot of DDX17 from uninfected or
RVFV-infected U2OS cells with immunoprecipita-
tion (IP) using anti-DDX17 or anti-FLAG (control).
Input, IP, and unbound fractions are shown, with
high efficiency of DDX17 IP.
(B) Autoradiograph of immunopurified and 32P-
labeled DDX17-RNA complexes transferred to
nitrocellulose membrane. Immunoprecipitation
with anti-FLAG as a control shows high specificity
of the DDX17-RNA signal.
(C) Flowchart of CLIP-seq alignment and pro-
cessing pipeline, resulting in alignment clusters.
(D) Alignment clusters overlapping annotated re-
gions of the genome (refSeq) were further
searched for significant peaks, and the overlap
between infected and uninfected DDX17 signifi-
cant CLIP-seq peaks (FDR < 0.001) in protein-
coding genes from refSeq at increasing peak
height is plotted. R2 = 0.88.
(E) Percentage of total nucleotides under signifi-
cant CLIP-seq peaks within refSeq protein-coding
genes broken down into transcript feature types
extracted from refSeq.
(F) Composite motif logo of the multiple sequence
alignment of the 20 most enriched hexamers
under significant CLIP-seq peaks within protein-
coding genes as identified by Z score, comparing
hexamer frequencies to 100 permutations of
binding-site locations within bound transcripts for
uninfected (top) or infected (bottom) cells.
See also Figure S5 and Table S2.In contrast, we foundnocorrelation betweenCLIP-seq signal and
level of miRNA expression reported in a previous study of small
RNAs in U2OS cells, indicating that DDX17 clusters represent
bias for certain miRNAs independent of expression level (Fig-
ure 6B). Among DDX17-bound miRNAs, miR-663a, miR-99b,
andmiR-6087were someof themost highly representedmiRNAs
(Figure 6C). Analysis of DDX17 CLIP signal in relation to the pre-
dicted pri-miRNA stem loop showed that DDX17 clusters were
preferentially localized immediately 50 and 30 to the center of
the loop (Figure 6D). These data suggest that DDX17 interactions
are strongest with the stem region of the miRNA hairpin rather
than the loop. Analysis of overrepresented hexamers in DDX17-
associated miRNAs did not show any enrichment of the CA- or
CT-repeat elements found with the DDX17 mRNA peaks (Table
S4). Furthermore, de novo analysis of the bound pri-miRNAs
identified no significantly enriched motifs compared to total
pri-miRNA background. Thus, the interaction of DDX17 with
pri-miRNAs is likely determined by RNA secondary structure.
DDX17 Binds RVFV RNAs to Restrict Viral Replication
To determine whether DDX17 regulation of miRNA biogenesis is
directly involved in antiviral defense, we silenced the Micropro-Cell 158, 764–777cessor component Drosha in U2OS cells
(Figure S6A). Loss of Drosha had no
impact on RVFV replication, suggestingthat the antiviral mechanism of DDX17 is independent of Drosha
and the canonical miRNA pathway (Figures S6B and S6C). Using
luciferase reporter assays as previously described (Sabin et al.,
2009), we also found that Rm62 is not required for siRNA- or
miRNA-mediated silencing in Drosophila cells (Figure S6D).
These data indicate that DDX17 does not act through RNAi to
restrict RVFV infection.
Next, we tested whether DDX17 directly interacts with viral
RNA by analyzing the overlap of DDX17 CLIP clusters with the
RVFV genome. We observed multiple DDX17 clusters, with the
highest signal on the M and S segments (Figure 7A). These
data suggest that DDX17 binds RVFV RNA in infected U2OS
cells. In addition, DDX17 viral peaks did not overlap with CA-
and CT-repeat motifs, suggesting that DDX17-viral interactions
are not dependent on these elements (Figure S6E).
Because viral RNAs are often highly structured and DDX17
was enriched at the stem region of pri-miRNA hairpins, we hy-
pothesized that DDX17 may recognize structured elements in
RVFV RNAs. Indeed, we observed a prominent CLIP cluster
within the intergenic region (IGR) on the S segment (between N
and NSs). The IGR on other ambisense bunyaviruses has been
shown to form a highly complementary sequence that folds, August 14, 2014 ª2014 Elsevier Inc. 771
Figure 6. DDX17 Directly Binds miRNA
Stem Loops in Human U2OS Cells
(A) Normalized CLIP-seq signal (TPKM, tags per
kilobase of pre-miRNA per million CLIP-seq
reads) in pre-miRNA hairpin loci with CLIP signal
extracted from miRBase. Linear regression of in-
fected TPKM on uninfected TPKM is plotted, R2 =
0.79.
(B) Scatterplot of miRNAs that are bound;
normalized pre-miRNA expression (RPKM) from
small RNA-seq and the mean of normalized CLIP-
seq signal (TPKM) between infected and unin-
fected U2OS cells are plotted, R2 = 0.001.
(C) Alignment clusters overlapping miRBase pre-
miRNA hairpin loci on the UCSC genome browser
with uninfected cells colored black and infected
cells colored red.
(D) RNA map of DDX17 CLIP signal in pre-miRNA
hairpins. Fraction of 160 hairpins bound is plotted
at single-nucleotide resolution relative to the
center of the stem loop.
See also Tables S3 and S4.into a hairpin to control transcription termination (Emery and
Bishop, 1987). This IGR in the RVFV antigenome similarly forms
a hairpin that generates the majority of virus-derived siRNAs in
infected Drosophila and mosquito cells (Sabin et al., 2013). We
defined a 75 nt RNA that overlaps the largest S segment
DDX17 CLIP cluster within the IGR on the genome strand, which
is predicted to form a hairpin structure that resembles miRNA
stem loops (Figure 7B). We synthesized this RNA in vitro using
T7 RNA polymerase to test whether it is bound by DDX17. Bio-
tinylated DDX17 peak RVFV RNA efficiently precipitated
DDX17 from U2OS cell lysates in a dose-dependent manner,
demonstrating that DDX17 physically interacts with RVFV RNA
and validating our CLIP-seq results (Figure 7C). In contrast, a
nonspecific control from RVFV RNA not bound in our CLIP-seq
data set did not precipitate DDX17 (Figure 7D).
To determinewhether DDX17 binding on viral RNA can directly
restrict viral infection, we cloned the RVFVDDX17 hairpin into the
30 UTR of SINV under the control of a subgenomic promoter
(SINV-hp). This same strategy has been previously shown to
tolerate the insertion of noncoding hairpin RNAs (Shapiro et al.,
2010). We found that control cells supported substantially less
infection of SINV-hp compared to wild-type (WT) SINV (Fig-
ure 7E). Furthermore, whereas depletion of DDX17 led tomodest
increases in SINV capsid production of WT virus, loss of DDX17
led to large increases in capsid production from SINV-hp
virus (Figure 7E). In addition, we tested whether this RVFV772 Cell 158, 764–777, August 14, 2014 ª2014 Elsevier Inc.hairpin also impacted SINV replication
in Drosophila cells. WT SINV was unaf-
fected by the loss of Rm62 (Figure 7F).
Moreover, as we found in human cells,
control RNAi-treated cells supported
less infection of SINV-hp than WT SINV,
and depletion of Rm62 led to a large in-
crease in SINV capsid production from
SINV-hp virus (Figure 7F). A second
DDX17 peak at the 50 end of the S
genomic segment was also predicted to form a hairpin (Fig-
ure S6F), and cloning this hairpin into SINV (SINV-50hp) also
sensitized the virus to DDX17 restriction in Drosophila and hu-
man cells (Figures S6G and S6H). Together, these data demon-
strate that the presence of a DDX17-binding site on viral RNA is
restrictive and that this repression can be alleviated by loss of
DDX17 across hosts.
We next assessed the localization of DDX17 and DDX5 during
infection by immunofluorescence, as RVFV and SINV RNA repli-
cation occur exclusively in the cytoplasm.We validated the spec-
ificity of these antibodies for immunofluorescence using RNAi
(Figures S6I and S6J). As previously reported, DDX17 was found
in the nucleus in uninfected cells (Figure 7G) (Bortz et al., 2011). At
12 hpi, however, we observed some DDX17 staining in cytosolic
puncta that colocalized with RVFV nucleocapsid protein N, which
coats viral RNA and facilitates replication (Figure 7G). In contrast,
DDX5 remained in the nucleus in the presence and absence of
infection (Figure 7H), suggesting a distinct localization pattern
for DDX17. Collectively, these data suggest that DDX17 may
gain access to cytosolic RVFV replication complexes during
infection and bind viral RNA to antagonize viral replication.
DISCUSSION
Emerging data have begun to uncover specialized functions
for mammalian DEAD-box helicases in immunity, particularly in
Figure 7. DDX17 Binds RVFV RNA to Restrict Viral Infection
(A) DDX17CLIP-seq clusters aligned to the RVFV tripartite genome, plotted 30 to 50 (genome orientation) along the x axis. Binding sites thatmap to the genome are
below and to the antigenome are above the line. CLIP-seq signal intensity (black) is measured in total overlapping reads at each nucleotide position.
(B) Predicted secondary structure of a 75 nt RNA from DDX17 CLIP peak on the RVFV S segment between N and NSs as determined by RNA fold (asterisk in A).
(C) The 75 nt DDX17 CLIP peak RNA from (B) was synthesized by T7 in vitro transcription and biotinylated. Biotinylated RVFV RNA was incubated with U2OS cell
protein lysates and immunoprecipitated, and DDX17-RVFV RNA complexes were analyzed by immunoblot.
(D) RNA-protein interaction assays were performed as in (C) using the biotinylated RVFV stem loop and nonspecific control RNA from RVFV not bound in the
DDX17 CLIP-seq data set.
(E) Representative immunoblot of U2OS cells transfectedwith the indicated siRNAs and infectedwith SINVWTor SINV encoding the RVFV hairpin (SINV-hp) 8 hpi.
(F) Representative immunoblot of Drosophila cells treated with control (b-gal) or Rm62 dsRNA and infected with SINV WT or SINV-hp 24 hpi (moi = 0.3).
(G) Representative IF images of DDX17 and RVFV N from uninfected or infected U2OS cells 12 hpi (helicase, green; RVFV N,red; nuclei, blue).
(H) Representative IF images of DDX5 and RVFV N from uninfected or infected U2OS cells 12 hpi (helicase, green; RVFV N, red; nuclei, blue).
See also Figure S6.
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the sensing of viral nucleic acids to activate interferon induction
(Fullam and Schro¨der, 2013). However, whether DEAD-box hel-
icases play interferon-independent roles in antiviral immunity re-
mains unclear. Moreover, whether antiviral DEAD-box helicases
exist primarily in mammals or evolved immune functions in lower
organisms has not been fully explored. We have discovered a
specific and evolutionarily conserved role for the helicase
DDX17 in restricting infection with RVFV, a major human arbo-
virus that lacks effective therapeutics.
Through an RNAi screen in Drosophila cells, we identified
Rm62 as an anti-RVFV helicase gene. Rm62 is also essential
for resistance to RVFV infection in vivo, as RVFV-challenged
Rm62-deficient flies showed increased viral replication andmor-
tality. Loss of Rm62 increased LACV infection but not SINV, VSV,
or DCV infection, and silencing closely related DEAD-box heli-
case genes had no effect on RVFV. Thus, Rm62 is as an essential
and specific virus restriction factor in flies.
Mammals encode two orthologs of Rm62, DDX5 and DDX17,
which have been widely studied in transcriptional coactivation,
mRNA splicing, and miRNA processing. In addition, previous
studies have implicated DDX5 and DDX17 in promoting the repli-
cation of several viruses, such as hepatitis C virus and influenza
virus (Bortz et al., 2011; Goh et al., 2004). We found that silencing
DDX17 but not DDX5 increased RVFV replication in human
U2OS cells, whereas DDX17 overexpression inhibited RVFV
infection. Although we cannot unequivocally rule out any antiviral
function for DDX5, as DDX5 depletion upregulated DDX17
expression and we could not efficiently knock down both pro-
teins simultaneously in U2OS cells, basal DDX5 levels were not
able to compensate for DDX17 loss. Therefore, the antiviral ac-
tivity of DDX17 is evolutionarily conserved from invertebrates
to mammals, suggesting an ancient origin for DEAD-box heli-
cases in innate immunity.
DDX17 joins a growing list of antimicrobial DEAD-box proteins
that function as cytoplasmic sensors for viral nucleic acids. For
example, DDX41 binds DNA to control IFN-I and proinflamma-
tory cytokine induction (Zhang et al., 2011b). Additionally,
DDX3 interacts with IKKε and TBK-1 to regulate IFN-I activation
downstream of virus recognition (Soulat et al., 2008). In contrast,
DDX17 is dispensable for antiviral gene expression, suggesting
that DDX17 acts independently of IFN-I, which is distinct from
previously defined antiviral DEAD-box genes.
Previous reports have proposed that Rm62 and DDX17 regu-
late RNAi, which is a well-characterized antiviral pathway in in-
vertebrates. In Drosophila cells, Rm62 has been shown to bind
Ago2 and control siRNA-mediated silencing (Ishizuka et al.,
2002). Based on these findings, one study suggested that
Rm62-deficient flies infected with Drosophila X virus (DXV)
have increasedmortality due to defective antiviral RNAi (Zambon
et al., 2006); however, this study did not use sibling-matched or
uninfected controls and did not monitor viral replication. In
mammalian cells, DDX5 and DDX17 are found in the Micropro-
cessor complex and regulate miRNA biogenesis. However, our
data suggest that Rm62 and DDX17 restrict viral infection in an
RNAi-independent manner. First, we found that Rm62 controls
the replication of RVFV but not VSV, SINV, or DCV, viruses that
are restricted by antiviral RNAi in flies (Galiana-Arnoux et al.,
2006; Mueller et al., 2010; Sabin et al., 2009; van Rij et al.,774 Cell 158, 764–777, August 14, 2014 ª2014 Elsevier Inc.2006). Second, Rm62 has not been found to control siRNA- or
miRNA-mediatedRNAsilencing inmore recent in vitro and in vivo
screens, which we confirmed in our experiments (Cziko et al.,
2009; Zhou et al., 2008). Third, RNAi is not generally thought to
restrict viral infection in mammalian somatic cells, whereas its
antiviral function in embryonic and undifferentiated mammalian
cell types may be active (Cullen et al., 2013; Li et al., 2013; Mail-
lard et al., 2013). Lastly, depletion of the Microprocessor com-
ponent Drosha, which can act as an interferon-independent
antiviral factor (Shapiro et al., 2014), did not impact RVFV infec-
tion. Although there may be additional complexity and interplay
between DDX17, miRNA biology, and antiviral defense, our
data suggest that DDX17’s antiviral function is independent of
its role in miRNA biogenesis.
CLIP-seq studies revealed that DDX17 physically associates
with viral RNA to control viral infection. One of the DDX17-bind-
ing peaks, corresponding to the IGR between the N and NSs
genes on the genomic S segment, efficiently precipitated
DDX17 from cell lysates. Interestingly, this region forms an
extensive hairpin (Sabin et al., 2013), suggesting that DDX17
may recognize highly structured stem loops on viral RNAs.
Furthermore, in infected cells, DDX17 forms cytoplasmic puncta
overlapping with RVFV N. This relocalization to viral replication
complexes may allow DDX17 to access and bind structured viral
RNA elements and thereby limit replication.
Indeed, by expressing the RVFV hairpin from SINV (SINV-hp),
we demonstrated that SINV becomes hypersensitive to DDX17
in both human and insect cells. This suggests that binding of
DDX17 to viral RNA is sufficient to mediate its antiviral effect.
How this binding limits viral replication remains to be clarified
in future studies. DDX17 may associate with additional protein
cofactors that mediate its antiviral function. For instance,
DDX17 has been shown to bind Dcp2 and Dcp1a, which re-
move the 50 cap from mRNAs, and the exonuclease Xrn1, which
mediates 50-to-30 RNA degradation (Zhu et al., 2011). Interest-
ingly, a recent study showed that Drosophila Dcp2 restricts
RVFV infection, although this may be in an indirect manner by
limiting the pool of cellular mRNA substrates that RVFV utilizes
for its own replication (Hopkins et al., 2013). DDX5 and DDX17
also bind components of the RNA exosome, a complex that
catalyzes 30-to-50 RNA degradation (Chen et al., 2008; Zonta
et al., 2013). Consequently, DDX17 may act as the sensor
that brings viral RNA targets to the RNA degradation machin-
ery, or it may unwind viral RNAs to facilitate degradation. The
decapping machinery, exosome, and DDX17 have additionally
been linked to the antiviral protein ZAP (Zhu et al., 2011). ZAP
is known to restrict SINV replication in human cells (Bick
et al., 2003), and we found a modest effect of DDX17 depletion
on WT SINV, albeit this effect was not as strong as with SINV-
hp. In contrast, flies do not encode a ZAP homolog, and Rm62
silencing had no impact on WT SINV replication in insect cells.
As maximal DDX17 restriction of SINV depended on the RVFV
stem loop in both cells types, DDX17’s antiviral function in
RVFV infection is likely independent of ZAP and dependent
on direct viral RNA binding.
Why DDX17 specifically targets bunyaviral RNAs is also
uncertain, as the rules that direct RNA-binding activity of
DDX17, as well as DEAD-box proteins in general, are difficult
to decipher. We suspect that antiviral specificity derives from a
combination of cellular localization and specific RNA struc-
tures. Our data suggest that SINV and VSV do not have the
appropriate targeting signals. In addition, the correlation be-
tween DDX17 expression pattern and viral pathogenesis must
be characterized. DDX17 is ubiquitously expressed and is not
transcriptionally induced by IFN-I, and our data suggest that
subcellular localization but not expression level is responsive
to infection. Further studies will allow us to better define the
regulation of DDX17 and explore the relationship between tis-
sue type and antiviral activity.
Beyond elucidating new DDX17 functions in immunity, our
data reveal important insights into the mechanism of DDX17
recognition for diverse RNAs. Our data suggest that DEAD-box
proteins are highly amenable to CLIP-seq analysis. We found
that DDX17 cellular mRNA targets are enriched for CT- and
CA-repeat elements, suggesting that primary sequence contrib-
utes to mRNA recognition. In contrast, DDX17-bound pri-miR-
NAs were not enriched for this element or any other linear
sequence (p > 0.05); instead, DDX17 was localized to the miRNA
stem, suggesting that it recognizes pri-miRNAs via secondary
structure. We compared our bound pri-miRNAs with two studies
that monitoredmiRNAs upon loss of DDX17 (Fukuda et al., 2007;
Mori et al., 2014). Fukuda et al. identified 94 miRNAs that were
decreased upon loss of p72 in mouse embryonic fibroblasts
that derive from 82 pre-miRNAs expressed in U2OS cells, of
which 32% were directly bound by DDX17 in our studies. In
another study, Mori et al. identified 317 miRNAs misregulated
by DDX17 depletion in HaCaT cells; of the 160 DDX17-bound
miRNAs from our study, 60 were analyzed in their cells, and 30
were found to be regulated by DDX17 (50%). Furthermore,
Mori et al. identified a sequence motif in the 30 flanking segment
of a subset of pri-miRNAs that were impacted by DDX17 levels
([GTA]CATC[CTA]) and focused on miR-21, a miRNA that we
also identified as bound by DDX17. Mori et al. demonstrated
by in vitro binding assays that both the motif as well as a com-
plete stem loop were required for full binding activity. Altogether,
these data suggest that DDX17 recognizes the pri-miRNA stem
in the context of a 30 tail. This would bias DDX17 binding to pri-
miRNAs over pre-miRNAs because some additional binding
energy would be derived from the flanking regions and would
facilitate DDX17 binding to stem loops within larger RNAs as is
found in viral RNAs. In further support of this, the ([GTA]CATC
[CTA]) sequencemotif was over-represented in our mRNA peaks
(p = 3.7 3 1017), suggesting that this sequence is indeed a
preferred binding site for DDX17 in diverse RNAs.
In conclusion, our data reveal striking parallels between
DDX17 recognition of pri-miRNAs and viral RNAs: in both cases,
DDX17 targets a structured stem loop, either to facilitate miRNA
processing or to mediate virus inhibition.
EXPERIMENTAL PROCEDURES
RNAi in Drosophila Cells
dsRNAs were synthesized as described (Boutros et al., 2004). Drosophila
cells were passaged into serum-free media and seeded onto 384-well or
6-well plates containing 250 ng or 4 mg of dsRNA/well, respectively. Com-
plete media was added 1 hr later, and the cells were incubated for 3 days
for knockdown.CLIP-Seq
U2OS cells were seeded onto 10 cmplates and infectedwith RVFV (multiplicity
of infection [moi] = 3) for 16 hr. The cells were washed in ice-cold HBSS
(GIBCO) and irradiated at 254 nm (400 mJ/cm2) in a Stratalinker 1800 (Strata-
gene). The cells were pelleted, flash frozen in liquid nitrogen, and stored
at 80C. Anti-DDX17 or anti-FLAG was bound to Dynabeads (Invitrogen) in
binding buffer (0.1 M Na-phosphate, pH 8, and 0.1% NP-40). Cell pellets
were lysed in 13 PXL (13 PBS (no Mg2+ and no Ca2+, 0.1% SDS, 0.5% deox-
ycholate and 0.5% NP-40) with protease inhibitors and RNasin, and lysates
were treated with RNase T1 (1:1000 dilution) and RQ1 DNase for 10 min at
37C. Lysates were incubated with beads overnight at 4C. RNA linkers
(RL3 and RL5) and DNA primers (DP3 and DP5, DSFP3 and DSFP5) were pre-
pared and used as described (Vourekas et al., 2012). Samples were resolved
by NuPAGE and transferred to nitrocellulose membrane, which was exposed
to film, and bands were excised above the expected molecular weight (MW) of
DDX17. RNA extraction, 50-linker ligation, RT-PCR, and reamplification were
performed as described (Vourekas et al., 2012). cDNA libraries were purified
and submitted for Illumina deep sequencing.
CLIP-Seq Data Analysis
Raw CLIP-seq reads were trimmed from the 30 end to remove 2+ contiguous
basecalls with Phred quality scores of 0. Sequencing adaptors were removed
from the 30 end with cutadapt version 0.9.4, and homopolymeric runs of 6+
basecalls of the same nucleotide were removed. Trimmed reads were aligned
to a composite genome index containing hg19 and RVFV strain MP-12 ge-
nomes, allowing at most two mismatches and retaining only unambiguous
alignments. PCR duplicates were removed by retaining only one alignment
for each 50 coordinate generating collapsed alignments. Genomic intervals
with at least two overlapping alignments were clustered together generating
the alignment clusters. Alignment clusters within annotated protein-coding
genes (refSeq NM_*) and ncRNA genes (refSeq NR_*) were further searched
for significant peaks with an empirical algorithm, using 100 iterations of permu-
tations and a FDR threshold of 0.001 (Xue et al., 2009).
DDX17-pre-miRNA interactions were identified by intersection of alignment
clusters with pre-miRNA loci extracted from miRBase release 20. Mature
miRNAs were associated with pre-miRNAs and 160 pre-miRNAs had at least
one CLIP cluster in either uninfected or infected cells. For those pre-miRNAs,
we included the total number of collapsed alignments for subsequent analysis.
To analyze miRNA expression levels in U2OS cells, we aligned small RNA-seq
reads from all three replicates of control-transfected U2OS cells (GEO submis-
sion GSM889286) (Wei et al., 2012) using the same alignment settings as
above and computed mean RPKM values for each pre-miRNA hairpin from
miRBase. To identify the relative location of DDX17 binding on pre-miRNA
loci, center coordinates for each pre-miRNA locus from miRBase were
computed, then intervals from 250 nt to +250 nt around the center were
generated. Intervals that do not intersect any CLIP cluster were discarded.
For each locus, the clusters were compressed such that each nucleotide
was bound or unbound (0 or 1). These were summed across the loci and
divided by the total to present the fraction bound at each position.
Computation was executed on the Penn Genome Frontiers Institute High
Performance Compute cluster, using Perl version 5.16.2, Python version
2.7.3, R version 3.0.2, bedtools version 2.16.2, and samtools version 0.1.18.
Motif Enrichment Analysis
Each hexamer occurring within DDX17-pre-mRNA interaction sites was as-
signed a Z score by comparing observed hexamer frequencies to the back-
grounds computed by permutation of the coordinates of interaction sites
100 times within the pre-mRNA in which that site occurred. Multiple sequence
alignments of the top 20 hexamers were generated with ClustalW2, and
sequence logos were generated with WebLogo version 2.8.
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